# A Trial of Degarelix in Patients With Prostate Cancer

> **NCT00946920** · PHASE3 · COMPLETED · sponsor: **Ferring Pharmaceuticals** · enrollment: 859 (actual)

## Conditions studied

- Prostate Cancer

## Interventions

- **DRUG:** Degarelix
- **DRUG:** Goserelin acetate

## Key facts

- **NCT ID:** NCT00946920
- **Lead sponsor:** Ferring Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-06
- **Primary completion:** 2011-03
- **Final completion:** 2011-03
- **Target enrollment:** 859 (ACTUAL)
- **Last updated:** 2014-06-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00946920

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00946920, "A Trial of Degarelix in Patients With Prostate Cancer". Retrieved via AI Analytics 2026-08-11 from https://api.ai-analytics.org/clinical/NCT00946920. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*